NPR News: Gene Therapy Shows Promise For Hemophilia, But Could Be Most Expensive U.S. Drug Ever

Gene Therapy Shows Promise For Hemophilia, But Could Be Most Expensive U.S. Drug Ever
The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.

Read more on NPR
Health & Science - July 20, 2020 at 06:13PM - Gene Therapy Shows Promise For Hemophilia, But Could Be Most Expensive U.S. Drug Ever